31 October 2014
: Case report
Terlipressin-Induced Ischemic Skin Necrosis: A Rare Association
Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)
Banu Demet Ozel CoskunABE, Ahmet KaramanBF, Hasan GorkemBD, Irfan BuğdayDF, Orhan Kursad PoyrazoğluBF, Fatma SenelGDOI: 10.12659/AJCR.891084
Am J Case Rep 2014; 15:476-479
Abstract
BACKGROUND: Terlipressin is a synthetic vasopressin analogue that is used in the treatment of bleeding esophageal varices and hepatorenal syndrome in patients with cirrhosis. Serious ischemic adverse events, such as skin necrosis involving the extremities, scrotum, trunk, and abdominal skin, are rarely observed. In the literature to date, 20 cases that developed ischemic skin necrosis due to terlipressin usage have been reported.
CASE REPORT: We report a patient with extensive skin necrosis on the infusion site of the right forearm and hand, which developed after the use terlipressin used to treat bleeding oesophageal varices in a 65-year-old man with cirrhosis.
CONCLUSIONS: Although rare, ischemic complications of terlipressin do occur.
Keywords: Biopsy, Diagnosis, Differential, Forearm, Gastrointestinal Hemorrhage - drug therapy, Lypressin - therapeutic use, Necrosis - pathology, Skin Diseases - pathology, Vasoconstrictor Agents - therapeutic use
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948283
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947725
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947694
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947174
Most Viewed Current Articles
21 Jun 2024 : Case report
102,230
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
54,598
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
38,437
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
26,104
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200